Creation of the company Poladerme
Paris, October 7, 2021 – ARCHOS announces the creation of Poladerme, a subsidiary of Medical Devices Venture.
The ambition of the startup Poladerme is to become a leader in spectropolarimetry combined with Artificial Intelligence and machine learning, applied to dermatology.
Poladerme, a company developed by Conectus, Strasbourg’s SATT (Société d’Accélération du Transfert de Technologies), is developing an innovative, rapid and non-invasive diagnostic solution based on an optical system and Artificial Intelligence algorithms for in-depth analysis of tissues and assessment of the skin’s health.
Poladerme: a company born out of research in spectropolarimetry and dealing with the processing and analysis of databases
Within the ICube laboratory of the University of Strasbourg, France, Professors Jihad Zallat and Christian Heinrich have been conducting research on spectropolarimetry and image processing and analysis techniques for more than 10 years in the TRIO and IMAGES research teams. The biomedical field is the privileged application framework.